JP2016537362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016537362A5 JP2016537362A5 JP2016530925A JP2016530925A JP2016537362A5 JP 2016537362 A5 JP2016537362 A5 JP 2016537362A5 JP 2016530925 A JP2016530925 A JP 2016530925A JP 2016530925 A JP2016530925 A JP 2016530925A JP 2016537362 A5 JP2016537362 A5 JP 2016537362A5
- Authority
- JP
- Japan
- Prior art keywords
- fold
- cells
- composition
- human placental
- placental perfusate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 31
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 27
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 27
- 230000003169 placental effect Effects 0.000 claims 14
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 3
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 3
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 3
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 3
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 3
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 3
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 claims 3
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 3
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 claims 3
- 102000008730 Nestin Human genes 0.000 claims 3
- 108010088225 Nestin Proteins 0.000 claims 3
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims 3
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 claims 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 3
- 210000005055 nestin Anatomy 0.000 claims 3
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 208000001738 Nervous System Trauma Diseases 0.000 claims 2
- 208000012902 Nervous system disease Diseases 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 208000028412 nervous system injury Diseases 0.000 claims 2
- 206010068051 Chimerism Diseases 0.000 claims 1
- 206010066476 Haematological malignancy Diseases 0.000 claims 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 1
- 206010070511 Hypoxic-ischaemic encephalopathy Diseases 0.000 claims 1
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 claims 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 claims 1
- 208000014951 hematologic disease Diseases 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 230000010412 perfusion Effects 0.000 claims 1
- 208000033300 perinatal asphyxia Diseases 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361905076P | 2013-11-15 | 2013-11-15 | |
| US201361905077P | 2013-11-15 | 2013-11-15 | |
| US61/905,076 | 2013-11-15 | ||
| US61/905,077 | 2013-11-15 | ||
| PCT/US2014/065665 WO2015073800A2 (en) | 2013-11-15 | 2014-11-14 | Compositions comprising human placental perfusate cells, subpopulations thereof, and their uses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019162780A Division JP2020019777A (ja) | 2013-11-15 | 2019-09-06 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016537362A JP2016537362A (ja) | 2016-12-01 |
| JP2016537362A5 true JP2016537362A5 (https=) | 2018-03-29 |
Family
ID=53058264
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530925A Pending JP2016537362A (ja) | 2013-11-15 | 2014-11-14 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
| JP2019162780A Withdrawn JP2020019777A (ja) | 2013-11-15 | 2019-09-06 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
| JP2021155038A Withdrawn JP2022020622A (ja) | 2013-11-15 | 2021-09-24 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
| JP2023176697A Pending JP2024016037A (ja) | 2013-11-15 | 2023-10-12 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019162780A Withdrawn JP2020019777A (ja) | 2013-11-15 | 2019-09-06 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
| JP2021155038A Withdrawn JP2022020622A (ja) | 2013-11-15 | 2021-09-24 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
| JP2023176697A Pending JP2024016037A (ja) | 2013-11-15 | 2023-10-12 | ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160279171A1 (https=) |
| EP (1) | EP3068432A4 (https=) |
| JP (4) | JP2016537362A (https=) |
| KR (3) | KR20160098244A (https=) |
| CN (2) | CN105916521A (https=) |
| AU (3) | AU2014348454A1 (https=) |
| CA (1) | CA2930573C (https=) |
| MX (2) | MX2016006270A (https=) |
| RU (1) | RU2016123361A (https=) |
| WO (1) | WO2015073800A2 (https=) |
| ZA (1) | ZA201603270B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11707491B2 (en) * | 2016-11-11 | 2023-07-25 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Methods of treating neurodegenerative disorders |
| EP3595683A1 (en) * | 2017-03-15 | 2020-01-22 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| JP2022513164A (ja) * | 2018-11-30 | 2022-02-07 | セルラリティ インク． | 胎盤由来同種ｃａｒ－ｔ細胞およびその使用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10001172A1 (de) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
| US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
| EP2305795B1 (en) | 2000-12-06 | 2019-07-03 | Celularity, Inc. | Method of collecting placental stem cells |
| US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| ES2432493T3 (es) * | 2001-02-14 | 2013-12-03 | Anthrogenesis Corporation | Placenta de mamífero post-parto, su uso y células madre de la misma |
| EP2316918B1 (en) * | 2001-02-14 | 2015-07-01 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| AU2005228442A1 (en) * | 2004-03-29 | 2005-10-13 | Cytomatrix, Llc | Methods for production of regulatory T cells and uses thereof |
| NZ597304A (en) * | 2005-10-13 | 2013-06-28 | Anthrogenesis Corp | Immunomodulation using placental stem cells |
| WO2007087292A2 (en) * | 2006-01-23 | 2007-08-02 | Athersys, Inc. | Mapc treatment of brain injuries and diseases |
| EP1976978A2 (en) * | 2005-12-29 | 2008-10-08 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
| PL2471907T3 (pl) | 2005-12-29 | 2019-07-31 | Celularity, Inc. | Populacje komórek macierzystych łożyska |
| EP4094578A1 (en) * | 2006-05-11 | 2022-11-30 | Celularity Inc. | Methods for collecting and using placenta cord blood stem cells |
| US8562972B2 (en) | 2006-10-23 | 2013-10-22 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
| CA2677679A1 (en) * | 2007-02-12 | 2008-08-21 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
| CA2688504A1 (en) * | 2007-06-18 | 2008-12-24 | Children's Hospital & Research Center At Oakland | Method of isolating stem and progenitor cells from placenta |
| KR20220122774A (ko) * | 2007-09-26 | 2022-09-02 | 셀룰래리티 인코포레이티드 | 인간 태반 관류액으로부터의 혈관형성 세포 |
| RU2536242C2 (ru) * | 2007-09-28 | 2014-12-20 | Антродженезис Корпорейшн | Угнетение опухолей с помощью плацентарного перфузата человека и выделенных из плаценты человека вспомогательных натуральных клеток-киллеров |
| DK2375907T3 (da) * | 2008-11-21 | 2019-06-11 | Celularity Inc | Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller |
| EP2405912A2 (en) * | 2009-03-12 | 2012-01-18 | University Of South Florida | Method of disease-induced and receptor-mediated stem cell neuroprotection |
| WO2010141654A1 (en) * | 2009-06-05 | 2010-12-09 | Anthrogenesis Corporation | Improved method of collecting placental cells |
| US20120177618A1 (en) * | 2009-07-14 | 2012-07-12 | Massachusetts Institute Of Technology | Hematopoietic stromal progenitor cells and uses thereof |
| US20110280849A1 (en) | 2010-03-26 | 2011-11-17 | Anthrogenesis Corporation | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
| DK2556145T3 (en) * | 2010-04-07 | 2016-11-07 | Anthrogenesis Corp | Angiogenesis using placental stem cells |
| MX342995B (es) * | 2010-07-13 | 2016-10-21 | Anthrogenesis Corp | Métodos de generar células asesinas naturales. |
| KR20190114045A (ko) * | 2010-12-17 | 2019-10-08 | 안트로제네시스 코포레이션 | 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료 |
| WO2012083023A1 (en) | 2010-12-17 | 2012-06-21 | Anthrogenesis Corporation | Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells |
| AR084753A1 (es) * | 2010-12-30 | 2013-06-05 | Anthrogenesis Corp | Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp) |
| WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
| CN114134113A (zh) | 2012-08-13 | 2022-03-04 | 人类起源公司 | 自然杀伤细胞及其用途 |
| DK2909314T3 (da) | 2012-10-19 | 2021-03-08 | Celularity Inc | Behandling af smerte med amnion afledte vedhæftende celler |
-
2014
- 2014-11-14 KR KR1020167015654A patent/KR20160098244A/ko not_active Ceased
- 2014-11-14 KR KR1020217030425A patent/KR20210121277A/ko not_active Ceased
- 2014-11-14 AU AU2014348454A patent/AU2014348454A1/en not_active Abandoned
- 2014-11-14 CA CA2930573A patent/CA2930573C/en active Active
- 2014-11-14 JP JP2016530925A patent/JP2016537362A/ja active Pending
- 2014-11-14 US US15/036,649 patent/US20160279171A1/en not_active Abandoned
- 2014-11-14 CN CN201480073194.6A patent/CN105916521A/zh active Pending
- 2014-11-14 MX MX2016006270A patent/MX2016006270A/es unknown
- 2014-11-14 WO PCT/US2014/065665 patent/WO2015073800A2/en not_active Ceased
- 2014-11-14 RU RU2016123361A patent/RU2016123361A/ru unknown
- 2014-11-14 KR KR1020247005001A patent/KR20240023709A/ko not_active Ceased
- 2014-11-14 CN CN202110968902.4A patent/CN113679740A/zh active Pending
- 2014-11-14 EP EP14862931.4A patent/EP3068432A4/en not_active Withdrawn
-
2016
- 2016-05-13 MX MX2021003799A patent/MX2021003799A/es unknown
- 2016-05-13 ZA ZA2016/03270A patent/ZA201603270B/en unknown
-
2018
- 2018-11-23 US US16/199,116 patent/US20190117705A1/en not_active Abandoned
-
2019
- 2019-09-06 JP JP2019162780A patent/JP2020019777A/ja not_active Withdrawn
-
2020
- 2020-03-27 AU AU2020202182A patent/AU2020202182A1/en not_active Abandoned
-
2021
- 2021-09-24 JP JP2021155038A patent/JP2022020622A/ja not_active Withdrawn
-
2022
- 2022-08-12 AU AU2022215291A patent/AU2022215291A1/en not_active Abandoned
-
2023
- 2023-10-12 JP JP2023176697A patent/JP2024016037A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201902574RA (en) | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof | |
| MX2022009849A (es) | Composicion y metodos para regular interacciones inhibitorias en celulas geneticamente modificadas. | |
| SA520411910B1 (ar) | تركيبات وطرق لعلاج اضطرابات مناعية باستخدام سلالات بكتيرية من المكورات اللبنية المعدلة للمناعة | |
| WO2016011210A3 (en) | Engineered cells for adoptive cell therapy | |
| WO2017077394A3 (en) | Materials and methods for treatment of hemoglobinopathies | |
| ZA202201874B (en) | Anti-hla-g antibodies, compositions comprising anti-hla-g antibodies and methods of using anti-hla-g antibodies | |
| WO2016135558A3 (en) | Materials and methods for treatment of hemoglobinopathies | |
| CN111601610A8 (zh) | 使用布劳特氏菌属菌株治疗疾病的组合物和方法 | |
| SA518392101B1 (ar) | ROR-Gamma مشتقات البنزيميدازول في صورة مُعدلات لـ | |
| CL2016003293A1 (es) | Inhibidores de mnk y método relacionado al mismo | |
| JP2024016037A5 (https=) | ||
| JP2015131795A5 (https=) | ||
| JP2014087372A5 (https=) | ||
| WO2013006474A3 (en) | Requlatora t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127 | |
| MX376062B (es) | Agonistas del receptor muscarinico. | |
| MX2009006786A (es) | Composiciones y metodos para el tratamiento de infecciones y tumores. | |
| JP2015159895A5 (https=) | ||
| SG10201804052UA (en) | hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS | |
| WO2016014434A3 (en) | Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodies | |
| MX2017004950A (es) | Composiciones y metodos para tratar el insomnio. | |
| NZ741724A (en) | Renal cell populations and uses thereof | |
| EA201790519A1 (ru) | Терапевтические соединения в качестве ингибиторов рецептора орексина-1 | |
| CO2018005983A2 (es) | Compuestos de isoindol | |
| JP2016537362A5 (https=) | ||
| WO2016048861A3 (en) | Heterocyclic compounds and use thereof |